Antimicrobial Use and Resistance in Brazil: An Overview of Regulatory Measures, Consumption Patterns, and Stewardship Challenges

Read full text Summarise with VIRAT
Authors: Maykon Jhuly Martins de Paiva, Walmirton Bezerra D’Alessandro, Renata Ferreira Diogo de Paiva, Iangla Araújo de Melo Damasceno, Juliane Farinelli Panontin, Taides Tavares dos Santos, Sávia Denise Silva Carlotto Herrera, Vitória Pires dos Santos Costa, Gabriela Pires Santomé de Faria, Guilherme Prazeres Matos de Souza, Márcio Trevisan
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antimicrobial resistance is one of the most important global public health challenges, particularly in low and middle-income countries where antimicrobial consumption remains high. In Brazil, several regulatory measures have been implemented over the last decade to improve control over antimicrobial use, including restrictions on over-the-counter sales and strengthened monitoring of antimicrobial dispensing. This article provides an overview of antimicrobial use, regulatory measures, and resistance-related challenges in Brazil. Evidence from epidemiological studies, antimicrobial dispensing records, national monitoring initiatives coordinated by the Brazilian Health Regulatory Agency (ANVISA), the National System for Controlled Product Management (SNGPC), and antimicrobial resistance surveillance efforts, including GLASS/BR-GLASS and national reports on healthcare-associated infections and resistance, was considered to identify trends in antimicrobial consumption, regional variation, and the influence of public health policies. Available data indicate that antibiotics such as amoxicillin, azithromycin, and cephalosporins remain among the most commonly dispensed antimicrobials in community settings. Regulatory measures have strengthened prescription requirements, improved oversight of antimicrobial dispensing, and reduced unrestricted non-prescription sales, although their broader impact on inappropriate clinical use and resistance trends remains heterogeneous across settings. Hospital settings continue to show high rates of broad-spectrum antimicrobial use, especially in intensive care units. The COVID-19 pandemic also influenced antimicrobial use patterns, particularly by increasing the consumption of macrolides despite limited evidence of bacterial coinfection. Continued efforts involving prescriber education, antimicrobial stewardship programs, microbiological diagnostics, and integrated surveillance are essential to support more rational antimicrobial use and help address antimicrobial resistance in Brazil.

Fields of Study & Subjects

Antibiotic Use and Resistance Antibiotic Resistance in Bacteria Pharmaceutical and Antibiotic Environmental Impacts

Publication details

Journal / source
Preprints.org
Publication date
20 March 2026
Language
EN
Document type
Preprint